World’s Biggest L-DOPA Production Base Ready For Operation
This article was originally published in PharmAsia News
Shandong Xinhua Pharmaceutical Co. Ltd. and Sankyo Chemical Industries Ltd. held a completion ceremony for their joint L-380 (drug name L-DOPA) project in Zibo city, Shandong province on Dec. 23. Initial production is to begin in early 2008 with a yearly output of 300 tonnes. The project will be the world's biggest L-380 production base when in full operation. L-DOPA, used for treating Parkinson's disease, is expected to grow at an annual rate of 13 percent globally to reach $2.3 billion by 2010. (Click here for more
You may also be interested in...
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
National export restrictions on medicines have been slammed by the international off-patent pharmaceutical industry as being “counter-productive” during the coronavirus crisis. The IGBA is instead urging international co-operation and transparency, pointing to a positive example of supply-chain connectivity in the Asia-Pacific region.
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.